MD Anderson Cancer Center is a world first-class cancer prevention, therapy and research center. MD Anderson is the largest independent cancer center in the world at present, with more than 50 buildings, an area of more than 1.56 million square meters, 656 beds as of the 2015 fiscal year, and close to 21,000 employees.
Ranked on US News and World Report’s list of “America’s Best Hospitals” for the last 12 years, MD Anderson ranked number one for 10 years in this period. In the latest ranking, it achieved full scores in terms of patient survival rates and patient-nurse ratios, and its specialized/expert reputation ranked first among the 900 cancer centers participating in the evaluation. In terms of scientific research, MD Anderson has received the largest amount of funding from the National Cancer Institute, and has 1,197 clinical research projects in progress, exceeding all other institutions in the U.S.
In the near future, we will build world-class Concord Cancer Hospitals in international medical parks in Shanghai. MD Anderson has provided consultants in the fields of spatial design, medical equipment, academic management, finance, human resources, and more.
At present, Concord Cancer Hospital is cooperating closely with MD Anderson Cancer Center. Most importantly,it hopes to introduce an excellent multidisciplinary care method and provide more effective and convenient medical care for cancer patients in China.The multidisciplinary integrated treatment of cancer refers to the application of the most current, effective, multidisciplinary therapy in a planned and reasonable way to meet the physical and psychological needs of the patient, the specific position of the cancer, its pathological pattern, affected area (stage), and development. Treatment combines changes in cellular and molecular biology, and strives to provide the best therapy at the most reasonable cost while also improving patients’ quality of life to the greatest extent.
To providemost appropriate treatment for the cancer patients with multidisciplinary care, essential specialists will work together to provide a tailored, integrated and seamless services for patients. Thus, patients are greatly benefited from this care delivery system as it encompasses expertise from all the major oncologic specialties of a specific disease and decreases the time and energy the patients spend coordinating appointments in various centers. More importantly, the timely on-site interaction, discussion and panning of care among clinicians can expedite the patient’s initiation of therapy.